Financial Disclosure - UW Institute for Clinical and ...

In accordance with Good Clinical Practice (GCP) (R2 dated March 2018), the Food and Drug Administration (FDA) Investigational New Drug (IND) regulations (21 CFR Part 312), Investigational Device Exemptions (IDE) regulations (21 CFR Part 812), and FDA Guidance for Clinical Investigators, Industry and FDA Staff: Financial Disclosure by Clinical Investigators (dated February 2013), this … ................
................